Choice of steroids for intratympanic therapy- a retrospective comparison

Weitgasser, Lennart and Tschani, Stefan and Kogler, Magdalena and Armstorfer, Maximilian and Schimetta, Wolfgang and Roesch, Sebastian (2025) Choice of steroids for intratympanic therapy- a retrospective comparison. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 282 (9). pp. 4579-4588. ISSN 0937-4477, 1434-4726

Full text not available from this repository. (Request a copy)

Abstract

Purpose Comparison of dexamethasone phosphate (DXA) and triamcinolone acetonide (TCA) for intratympanic therapy (IT) in patients with unilateral idiopathic sudden sensorineural hearing loss (ISSNHL) to reveal a potential superiority regarding the efficiency to improve hearing function. Methods Retrospective, monocentric, two-armed cohort-study. Analysis of clinical and audiometric data of patients treated with IT for unilateral ISSNHL. 118 adults, who received IT with DXA (n = 67) or TCA (n = 51) were included. Main outcome parameters were hearing improvement in percent and decibel (dB) in relation to the healthy ear within a follow-up period of three months. Response to therapy was defined as an improvement of at least 10dB in affected frequencies. Results Median improvement was 24.6% and 6.2 dB in the DXA group, 31.4% and 10.0 dB in the TCA group. For the response analysis, 7 patients dropped out. Of the remaining 111 patients, 27 (43,5%; 95%CI 30,9-56,7) in the DXA and 26 (53,0%; 95%CI 38,2-67,4) in the TCA group showed response. Analysis of the outcome parameters showed no statistically remarkable difference (p < 0,05) between the two cohorts. The difference of initial pure tone average between the affected and healthy ear and the time between symptom onset and first IT, was confirmed as an influencing factor to the outcome. Conclusion For intratympanic treatment of ISSNHL dexamethasone phosphate and triamcinolone acetonide seem equivalent considering its ability to improve hearing function. A more severe hearing loss and a short duration between onset and therapy may favor the chance of hearing recovery.

Item Type: Article
Uncontrolled Keywords: TRIAMCINOLONE ACETONIDE; BINDING; KINETICS; OPTION; Sudden hearing loss; SNHL; Intratympanic therapy; Dexamethasone; Triamcinolone acetonide
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Hals-Nasen-Ohren-Heilkunde
Depositing User: Dr. Gernot Deinzer
Date Deposited: 29 Sep 2026 05:19
Last Modified: 29 Sep 2026 05:19
URI: https://pred.uni-regensburg.de/id/eprint/67195

Actions (login required)

View Item View Item